Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

Objectives Azithromycin has recently replaced clindamycin oral suspension for prop hylaxis of infective endocarditis (IE) in children. It is also currently recommended by the American Heart ...

(HealthDay)—For patients undergoing lung transplantation (LTx), prophylactic azithromycin is associated with reduced risk of chronic lung allograft dysfunction (CLAD), according to a study ...

Azithromycin has replaced clindamycin oral suspension for prophylaxis against IE in children. Patient compliance with azithromycin should be good as it only needs to be taken once a day for 3 days ...

Azithromycin significantly reduced the frequency of exacerbations (1.48 vs. 1.83 per patient-year, P<0.01), and increased the median time to first exacerbation (266 days vs. 174 days, P<0.001).

For patients undergoing lung transplantation (LTx), prophylactic azithromycin is associated with reduced risk of chronic lung allograft dysfunction (CLAD).

David Juurlink’s timely and otherwise thorough review of chloroquine, hydroxychloroquine and azithromycin1 omitted an important safety consideration for azithromycin that is relevant to recipients of ...

Prophylactic benefits observed in real-world study. So we've established azithromycin is not a replacement, but it has a lot of benefits.

The women who received azithromycin were significantly less likely to experience a composite of endometritis, wound infection, or other infections within 6 weeks of delivery than women receiving ...

TOPLINE: Prophylactic azithromycin had no significant effect on survival without the development of chronic lung disease (CLD) in high-risk premature infants compared with placebo.

SALT LAKE CITY — Early azithromycin use did not affect hematologic relapse among pediatric hematopoietic stem cell transplant recipients, according to study results.Duration of azithromycin use ...

Treatment with azithromycin was associated with a lower frequency of long-term Shiga toxin-producing enteroaggregative Escherichia coli, according to researchers from Germany. For the study ...